BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38810062)

  • 1. Intralesional Quadrivalent Human Papilloma Virus Vaccine Versus Candida Antigen in the Treatment of Multiple Recalcitrant Non-Genital Warts.
    Fouda I; Mohammed HAK; Mohammed GMY
    Dermatol Pract Concept; 2024 Apr; 14(2):. PubMed ID: 38810062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intralesional bivalent and quadrivalent human papillomavirus vaccines didn't significantly enhance the response of multiple anogenital warts when co-administered with intralesional Candida antigen immunotherapy. A randomized controlled trial.
    Fawzy M; Nofal E; Abdelkhalek N; Ehab R
    Arch Dermatol Res; 2023 Dec; 315(10):2813-2823. PubMed ID: 37573268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple Intralesional Antigen Immunotherapy versus Monoantigen in the Treatment of Multiple Recalcitrant Warts.
    Nofal AA; Elkholy BM; Abd-Elmonsef ER; Nofal HO
    Dermatol Ther (Heidelb); 2022 May; 12(5):1225-1237. PubMed ID: 35449500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intralesional Candida antigen versus intralesional vitamin D3 in the treatment of recalcitrant multiple common warts.
    Abdel Razik LH; Obaid ZM; Fouda I
    J Cosmet Dermatol; 2021 Oct; 20(10):3341-3346. PubMed ID: 34228877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intralesional immunotherapy for multiple recalcitrant plantar warts: Candida antigen is superior to intralesional purified protein derivative.
    Nofal A; Adel L; Fawzy M; Elkholy BM
    Dermatol Ther; 2022 Jun; 35(6):e15440. PubMed ID: 35285995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Intralesional
    Zayan H; Hosny AH; Mamdouh MM; Tawfik YM
    J Cutan Med Surg; 2024; 28(3):253-258. PubMed ID: 38497287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined bivalent human papillomavirus vaccine and Candida antigen versus Candida antigen alone in the treatment of recalcitrant warts.
    Marei A; Nofal A; Alakad R; Abdel-Hady A
    J Cosmet Dermatol; 2020 Mar; 19(3):758-762. PubMed ID: 31328869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intralesional vitamin D3 versus Candida antigen immunotherapy in the treatment of multiple recalcitrant plantar warts: A comparative case-control study.
    Fathy G; Sharara MA; Khafagy AH
    Dermatol Ther; 2019 Sep; 32(5):e12997. PubMed ID: 31225688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT.
    Gilson R; Nugent D; Bennett K; Doré CJ; Murray ML; Meadows J; Haddow LJ; Lacey C; Sandmann F; Jit M; Soldan K; Tetlow M; Caverly E; Nathan M; Copas AJ
    Health Technol Assess; 2020 Sep; 24(47):1-86. PubMed ID: 32975189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of intralesional Candida antigen in diabetic patients with multiple warts.
    Marei A; Alakad R; Wahid RM
    J Cosmet Dermatol; 2021 Apr; 20(4):1248-1253. PubMed ID: 32924256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial.
    Goldstone SE; Giuliano AR; Palefsky JM; Lazcano-Ponce E; Penny ME; Cabello RE; Moreira ED; Baraldi E; Jessen H; Ferenczy A; Kurman R; Ronnett BM; Stoler MH; Bautista O; Das R; Group T; Luxembourg A; Zhou HJ; Saah A
    Lancet Infect Dis; 2022 Mar; 22(3):413-425. PubMed ID: 34780705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intralesional versus intramuscular bivalent human papillomavirus vaccine in the treatment of recalcitrant common warts.
    Nofal A; Marei A; Ibrahim AM; Nofal E; Nabil M
    J Am Acad Dermatol; 2020 Jan; 82(1):94-100. PubMed ID: 31369771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intralesional injection of purified protein derivative versus Candida antigen in treatment of genital warts.
    Tawfik NZ; Eyada MMK; Abdel El Hamid RE; Halim HM
    Dermatol Ther; 2022 Oct; 35(10):e15762. PubMed ID: 36056784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intralesional Measles, Mumps, and Rubella Vaccine Versus Intralesional
    Nofal A; El-Arab RE; Nasr M; Alakad R
    J Cutan Med Surg; 2021; 25(4):377-383. PubMed ID: 33533654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Cryo-immuno-therapy' is superior to intralesional
    Attwa E; Elawady R; Salah E
    J Dermatolog Treat; 2021 Dec; 32(8):1018-1025. PubMed ID: 32009473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Study of Intralesional Vitamin D3 Injection and Candida Albicans Antigen in Treating Plantar Warts.
    Abdelaal MA; Abdelaziz HM; Ahmed KA; Elsaie ML
    J Drugs Dermatol; 2021 May; 20(5):546-549. PubMed ID: 33938709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intralesional injection of Candida albicans antigen versus measles, mumps, and rubella vaccine for treatment of plantar warts.
    Rageh RM; Hewedy ES; Hegab DS
    Acta Dermatovenerol Alp Pannonica Adriat; 2021 Mar; 30(1):1-5. PubMed ID: 33765749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intralesional immunotherapy for the treatment of anogenital warts in pediatric population.
    Nofal A; Alakad R
    J Dermatolog Treat; 2022 Mar; 33(2):1042-1046. PubMed ID: 32703042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intralesional immunotherapy for pediatric warts: A review.
    Fields JR; Saikaly SK; Schoch JJ
    Pediatr Dermatol; 2020 Mar; 37(2):265-271. PubMed ID: 31930595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intralesional antigen immunotherapy for the treatment of plane warts: A comparative study.
    Fawzy MM; Nofal A; Alakad R
    Dermatol Ther; 2020 Nov; 33(6):e13807. PubMed ID: 32530550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.